Henderson Michael's most recent trade in Spyre Therapeutics Inc. was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spyre Therapeutics Inc. | Michael Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 05 Mar 2025 | 7,326 | 1,295,661 | - | 30.0 | 219,633 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.62 per share. | 05 Mar 2025 | 2,674 | 1,292,987 | - | 30.6 | 81,878 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.58 per share. | 05 Feb 2025 | 15,000 | 1,302,987 | - | 40.6 | 608,700 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.86 per share. | 31 Jan 2025 | 8,500 | 1,317,987 | - | 22.9 | 194,310 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 8,500 | 390,012 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc. | Michael Henderson | Director | Other type of transaction at price $ 0.00 per share. | 10 Jan 2025 | 105,379 | 105,379 (0%) | 0% | 0 | Common Stock | |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 357,036 | 357,036 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 04 Dec 2024 | 13,328 | 1,326,159 | - | 46.5 | 619,752 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.19 per share. | 04 Dec 2024 | 1,672 | 1,324,487 | - | 47.2 | 78,902 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.17 per share. | 06 Nov 2024 | 14,000 | 1,340,487 | - | 59.2 | 828,380 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.94 per share. | 06 Nov 2024 | 1,000 | 1,339,487 | - | 59.9 | 59,940 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.07 per share. | 02 Oct 2024 | 30,288 | 1,364,199 | - | 56.1 | 1,698,248 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.74 per share. | 02 Oct 2024 | 9,712 | 1,354,487 | - | 56.7 | 551,059 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 27.21 per share. | 06 Sep 2024 | 38,000 | 76,828 (0%) | 0% | 27.2 | 1,033,900 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.28 per share. | 04 Sep 2024 | 25,641 | 1,408,846 | - | 47.3 | 1,212,306 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.23 per share. | 04 Sep 2024 | 14,359 | 1,394,487 | - | 48.2 | 692,535 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 07 Aug 2024 | 32,233 | 1,442,254 | - | 40.4 | 1,302,213 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.52 per share. | 07 Aug 2024 | 7,667 | 1,434,587 | - | 41.5 | 318,334 | Common Stock |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.17 per share. | 07 Aug 2024 | 100 | 1,434,487 | - | 42.2 | 4,217 | Common Stock |
| Arya Sciences Acquisition ... | Michael Henderson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2024 | 30,000 | 0 | - | - | Class B ordinary shares | |
| Apogee Therapeutics Inc. | Michael Henderson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.26 per share. | 05 Jul 2024 | 15,000 | 1,474,487 | - | 37.3 | 558,900 | Common Stock |
| Spyre Therapeutics Inc. | Michael Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 11,323 | 11,323 | - | - | Stock Option (Right to Buy) | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 27.60 per share. | 25 Mar 2024 | 37,500 | 114,828 (0%) | 0% | 27.6 | 1,034,854 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2024 | 13,889 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 27.59 per share. | 25 Mar 2024 | 13,889 | 114,828 (0%) | 0% | 27.6 | 383,198 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 25 Mar 2024 | 13,889 | 128,717 (0%) | 0% | 10.5 | 145,418 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 40,650 | 167,394 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.60 per share. | 01 Mar 2024 | 15,066 | 152,328 (0%) | 0% | 24.6 | 370,624 | Common Stock |
| Marathon Oil Corporation | Michael Henderson A. | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 53,570 | 147,824 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | A. Henderson Michael | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.85 per share. | 31 Jan 2024 | 21,080 | 126,744 (0%) | 0% | 22.9 | 481,678 | Common Stock |
| Apogee Therapeutics Inc. | Henderson Michael | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 398,512 | 398,512 | - | - | Stock Option (Right to Buy) | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 27.30 per share. | 28 Sep 2023 | 37,000 | 94,254 (0%) | 0% | 27.3 | 1,010,174 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 26.91 per share. | 01 Sep 2023 | 20,000 | 131,254 (0%) | 0% | 26.9 | 538,234 | Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Sale of securities on an exchange or to another person at price $ 27.44 per share. | 04 May 2023 | 1,691 | 132,769 (0%) | 0% | 27.4 | 46,401 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.89 per share. | 01 May 2023 | 1,656 | 134,460 (0%) | 0% | 28.9 | 47,842 | Class A Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 31,795 | 162,149 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.79 per share. | 01 Mar 2023 | 10,895 | 151,254 (0%) | 0% | 25.8 | 280,982 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.86 per share. | 17 Feb 2023 | 9,020 | 130,354 (0%) | 0% | 25.9 | 233,257 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 47,755 | 153,005 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.86 per share. | 25 Jan 2023 | 13,631 | 139,374 (0%) | 0% | 27.9 | 379,760 | Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2022 | 12,421 | 136,116 (0%) | 0% | 0 | Class A Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 32.56 per share. | 08 Nov 2022 | 80,000 | 105,250 (0%) | 0% | 32.6 | 2,604,448 | Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Sale of securities on an exchange or to another person at price $ 26.36 per share. | 03 Nov 2022 | 16,823 | 123,695 (0%) | 0% | 26.4 | 443,454 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 27,062 | 155,449 (0%) | 0% | 0 | Class A Common Stock | |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.99 per share. | 31 Oct 2022 | 9,732 | 145,717 (0%) | 0% | 27.0 | 262,667 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.99 per share. | 31 Oct 2022 | 5,199 | 140,518 (0%) | 0% | 27.0 | 140,321 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.63 per share. | 02 May 2022 | 1,792 | 128,387 (0%) | 0% | 45.6 | 81,769 | Class A Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 24.73 per share. | 22 Mar 2022 | 40,000 | 185,250 (0%) | 0% | 24.7 | 989,144 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.47 per share. | 22 Mar 2022 | 27,777 | 213,027 (0%) | 0% | 10.5 | 290,825 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2022 | 27,777 | 13,889 | - | - | Employee Stock Option (Right to Buy) | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 24.73 per share. | 22 Mar 2022 | 27,777 | 185,250 (0%) | 0% | 24.7 | 686,872 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 24.73 per share. | 22 Mar 2022 | 23,529 | 185,250 (0%) | 0% | 24.7 | 581,863 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2022 | 23,529 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.79 per share. | 22 Mar 2022 | 23,529 | 208,779 (0%) | 0% | 16.8 | 395,052 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 27,174 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.52 per share. | 07 Mar 2022 | 27,174 | 252,424 (0%) | 0% | 14.5 | 394,566 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 24.11 per share. | 07 Mar 2022 | 24,388 | 228,036 (0%) | 0% | 24.1 | 587,995 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 24.12 per share. | 07 Mar 2022 | 2,786 | 225,250 (0%) | 0% | 24.1 | 67,198 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 29,488 | 232,277 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 22.19 per share. | 28 Feb 2022 | 25,913 | 202,789 (0%) | 0% | 22.2 | 575,090 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.89 per share. | 28 Feb 2022 | 7,027 | 225,250 (0%) | 0% | 22.9 | 160,848 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.88 per share. | 25 Feb 2022 | 10,313 | 228,702 (0%) | 0% | 21.9 | 225,648 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 21,202 | 244,551 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. | 26 Jan 2022 | 5,536 | 239,015 (0%) | 0% | 19.6 | 108,561 | Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2021 | 9,424 | 130,179 (0%) | 0% | 0 | Class A Common Stock | |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 14,522 | 140,217 (0%) | 0% | 0 | Class A Common Stock | |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Sale of securities on an exchange or to another person at price $ 52.11 per share. | 01 Nov 2021 | 7,721 | 120,755 (0%) | 0% | 52.1 | 402,341 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.80 per share. | 01 Nov 2021 | 6,449 | 133,768 (0%) | 0% | 53.8 | 346,956 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.80 per share. | 01 Nov 2021 | 5,292 | 128,476 (0%) | 0% | 53.8 | 284,710 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.21 per share. | 03 May 2021 | 1,793 | 127,320 (0%) | 0% | 47.2 | 84,648 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Sale of securities on an exchange or to another person at price $ 52.37 per share. | 03 May 2021 | 1,625 | 125,695 (0%) | 0% | 52.4 | 85,101 | Class A Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Sale of securities on an exchange or to another person at price $ 12.55 per share. | 11 Mar 2021 | 20,938 | 223,349 (0%) | 0% | 12.6 | 262,772 | Common Stock |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 53,571 | 244,287 (0%) | 0% | 0 | Common Stock | |
| Marathon Oil Corporation | Michael A. Henderson | Executive VP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.10 per share. | 26 Feb 2021 | 3,774 | 190,716 (0%) | 0% | 11.1 | 41,891 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 4,456 | 4,456 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 3,137 | 3,137 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 2,199 | 2,199 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 10,000 | 8,282 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 01 Dec 2020 | 10,000 | 284,211 (0%) | 0% | 1.1 | 10,500 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 51.69 per share. | 01 Dec 2020 | 6,972 | 274,211 (0%) | 0% | 51.7 | 360,408 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 51.12 per share. | 01 Dec 2020 | 3,028 | 281,183 (0%) | 0% | 51.1 | 154,796 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 12,813 | 179,375 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 12,813 | 280,564 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 16 Nov 2020 | 10,000 | 277,751 (0%) | 0% | 1.1 | 10,500 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 16 Nov 2020 | 10,000 | 267,751 (0%) | 0% | 45 | 450,000 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 18,282 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.33 per share. | 16 Nov 2020 | 6,353 | 274,211 (0%) | 0% | 44.3 | 281,628 | Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 17,688 | 129,113 (0%) | 0% | 0 | Class A Common Stock | |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 19,081 | 133,041 (0%) | 0% | 0 | Class A Common Stock | |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President of Operations | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 02 Nov 2020 | 10,630 | 111,425 (0%) | 0% | 21.5 | 228,758 | Class A Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 10,000 | 28,282 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 02 Nov 2020 | 10,000 | 277,751 (0%) | 0% | 1.1 | 10,500 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 38.33 per share. | 02 Nov 2020 | 9,500 | 268,251 (0%) | 0% | 38.3 | 364,100 | Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President of Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 02 Nov 2020 | 6,492 | 122,055 (0%) | 0% | 21 | 136,332 | Class A Common Stock |
| Radius Recycling Inc - Ord... | Michael R. Henderson | SVP, President of Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.00 per share. | 02 Nov 2020 | 4,494 | 128,547 (0%) | 0% | 21 | 94,374 | Class A Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 38.92 per share. | 02 Nov 2020 | 500 | 267,751 (0%) | 0% | 38.9 | 19,458 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 6,745 | 38,282 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 01 Oct 2020 | 6,745 | 277,751 (0%) | 0% | 1.0 | 7,082 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 39.28 per share. | 01 Oct 2020 | 5,505 | 267,751 (0%) | 0% | 39.3 | 216,249 | Common Stock |
| BridgeBio Pharma Inc | Michael Henderson | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 38.29 per share. | 01 Oct 2020 | 4,495 | 273,256 (0%) | 0% | 38.3 | 172,093 | Common Stock |